文献速递骨肌MR

关节腔内注射中分子量透明质酸对髋膝关节软骨的影响:T2映射的活体评估

Effect of intra-articular injection of intermediate-weight hyaluronic acid on hip and knee cartilage: in-vivo evaluation using T2 mapping.
PubMed 文献 · Eur Radiol · 2018-01-09

前瞻性纳入102例临床及MRI诊断的髋或膝I-III级软骨病变患者,72例接受关节腔内透明质酸注射,30例为对照,基线与第3、9、15个月行MRI T2映射及WOMAC评估。注射后第3个月膝与髋T2弛豫时间均较基线显著升高(p<0.001),第9、15个月回落至基线水平;III级软骨病变患者T2升高与疼痛减轻显著相关(r=0.54,p<0.01)。作者认为T2映射可用于评估关节腔内透明质酸注射的时效变化。

要点

  • 关节腔内透明质酸注射后第3个月膝与髋软骨T2弛豫时间较基线升高,第9、15个月回落至基线水平。
  • III级软骨病变患者T2升高与疼痛减轻显著相关(r=0.54,p<0.01)。
  • 内侧股骨髁T2弛豫时间与WOMAC变化相关,且Outerbridge I级与II-III级间T2弛豫时间不同。

核心结论

  • T2映射可用于评估髋膝关节软骨病变患者关节腔内透明质酸注射后的时效变化。

研究设计与样本

  • 前瞻性研究纳入102例临床及MRI诊断的髋或膝I-III级软骨病变患者,均行患侧髋/膝标准MRI及T2映射多回波序列;MRI评估后1个月,72例(男38例,平均年龄51±10岁)接受关节腔内透明质酸注射,30例(男15例,51±9岁)未治疗作为对照;所有患者基线与第3、9、15个月行MR及WOMAC评估。

关键影像表现/征象

  • 关节腔内透明质酸注射后,膝软骨T2弛豫时间从基线40.7±9.8 ms升高至治疗后第一个时间点45.8±8.6 ms(p<0.001)。
  • 关节腔内透明质酸注射后,髋软骨T2弛豫时间从基线40.9±9.7 ms升高至治疗后第一个时间点45.9±9.5 ms(p<0.001)。
  • 第9与15个月评估时T2弛豫时间回落至与基线相似的水平(与3个月相比p<0.001)。

诊断标准与关键数值

  • T2值取所有层面平均值用于分析。
  • III级软骨病变患者关节腔内透明质酸注射后T2升高与疼痛减轻的相关系数r=0.54,p<0.01。
  • 内侧股骨髁T2弛豫时间与WOMAC变化相关。
  • T2弛豫时间在Outerbridge I级与II-III级之间不同。

临床应用与阅片要点

  • 作者认为T2映射可用于评估髋膝关节软骨病变患者关节腔内透明质酸注射后的时效变化。
  • 关节腔内透明质酸注射后3个月T2弛豫时间升高,第9、15个月回落至基线水平,阅片报告时可结合时间点解读T2值变化。
  • III级软骨病变患者T2升高与疼痛减轻显著相关(r=0.54,p<0.01),内侧股骨髁T2与WOMAC变化相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We used T2 mapping to quantify the effect of intra-articular hyaluronic acid administration (IAHAA) on cartilage with correlation to clinical symptoms.

METHODS: One hundred two patients with clinical and MRI diagnosis of hip or knee grade I-III chondropathy were prospectively included. All patients received a standard MRI examination of the affected hip/knee (one joint/patient) and T2-mapping multiecho sequence for cartilage evaluation. T2 values of all slices were averaged and used for analysis. One month after MR evaluation 72 patients (38 males; mean age 51±10 years) underwent IAHAA. As a control group, 30 subjects (15 males; 51 ± 9 years) were not treated. MR and WOMAC evaluation was performed at baseline and after 3, 9, and 15 months in all patients.

RESULTS: T2 mapping in hyaluronic acid (HA) patients showed a significant increase in T2 relaxation times from baseline to the first time point after therapy in knees (40.7 ± 9.8 ms vs. 45.8 ± 8.6 ms) and hips (40.9 ± 9.7 ms; 45.9 ± 9.5 ms) (p < 0.001). At the 9- and 15-month evaluations, T2 relaxation dropped to values similar to the baseline ones (p < 0.001 vs. 3 month). The correlation between T2 increase and pain reduction after IAHAA was statistically significant (r = 0.54, p < 0.01) in patients with grade III chondropathy.

CONCLUSIONS: T2 mapping can be used to evaluate the effect over time of IAHAA in patients with hip and knee chondropathy.

KEY POINTS: • T2 relaxation times change over time after hyaluronic acid intra-articular administration • T2 relaxation times of the medial femoral condyle correlate with WOMAC variation • T2 relaxation times are different between Outerbridge I and II-III.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ferrero G, Sconfienza LM, Fiz F, et al. Effect of intra-articular injection of intermediate-weight hyaluronic acid on hip and knee cartilage: in-vivo evaluation using T2 mapping. Eur Radiol. 2018. PMID: 29318429. doi:10.1007/s00330-017-5186-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。